SLE: Novel Postulates for Therapeutic Options
Genetic deficiency in C1q is a strong susceptibility factor for systemic lupus erythematosus (SLE). There are two major hypotheses that potentially explain the role of C1q in SLE. The first postulates that C1q deficiency abrogates apoptotic cell clearance, leading to persistently high loads of poten...
Main Authors: | Kinga K. Hosszu, Alisa Valentino, Ellinor I. Peerschke, Berhane Ghebrehiwet |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.583853/full |
Similar Items
-
Expression and distribution of the complement receptor gC1qR in bovine sperm
by: Robert Valeris, et al.
Published: (2010-05-01) -
The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer
by: Berhane Ghebrehiwet, et al.
Published: (2024-04-01) -
Complement component C1q initiates extrinsic coagulation via the receptor for the globular head of C1q in adventitial fibroblasts and vascular smooth muscle cells
by: Christopher T. Freda, et al.
Published: (2023-01-01) -
Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer
by: Ellinor I. Peerschke, et al.
Published: (2020-10-01) -
Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation#.
by: Berhane eGhebrehiwet, et al.
Published: (2011-11-01)